AI as Enterprise-Wide Enabler of Clinical Trial Innovation – with Leaders from Medable, Takeda, Sanofi, Novartis, and Daiichi Sankyo
Emerj - AI Research
Aug 13, 2025 10:00
Marilie Fouche
1 views
airesearchbusinessapplications
Summary
Pharmaceutical leaders from Medable, Takeda, Sanofi, Novartis, and Daiichi Sankyo discuss how AI is driving innovation in clinical trials by enabling greater personalization, streamlining processes, and improving access. The article highlights AI’s role as an enterprise-wide enabler, helping companies manage increasing complexity and tighter timelines in drug development. This demonstrates AI’s growing impact on accelerating and optimizing clinical research across the industry.
This article is sponsored by Medable and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Clinical trials are becoming increasingly complex as pharmaceutical companies pursue more personalized therapies, navigate tighter timelines, and expand access […]